| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JSO.10186 |
| P698 | PubMed publication ID | 12561067 |
| P2093 | author name string | Ming Dong | |
| Yoshinori Nio | |||
| Takayuki Harada | |||
| Kunihiro Yamasawa | |||
| Tomoko Toga | |||
| Lishuang Yue | |||
| P2860 | cites work | TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material | Q36135944 |
| P433 | issue | 2 | |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 111-120 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Journal of Surgical Oncology | Q1919535 |
| P1476 | title | p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer. | |
| P478 | volume | 82 |
| Q37799830 | Challenges of drug resistance in the management of pancreatic cancer |
| Q39121040 | Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer |
| Q37340315 | Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved |
| Q39254783 | Down regulation of CAII is associated with tumor differentiation and poor prognosis in patients with pancreatic cancer |
| Q40479195 | Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas. |
| Q49184903 | Establishment of a human primary pancreatic cancer mouse model to examine and investigate gemcitabine resistance |
| Q38662152 | Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas |
| Q35142857 | Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma. |
| Q42112526 | Investigation of solvent effect and NMR shielding tensors of p53 tumor-suppressor gene in drug design |
| Q33672267 | Matrine reduces the proliferation of A549 cells via the p53/p21/PCNA/eIF4E signaling pathway |
| Q37859255 | Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. |
| Q37004734 | Molecular prognostic factors in patients with pancreatic cancer. |
| Q39746584 | Plumbagin, isolated from Plumbago zeylanica, induces cell death through apoptosis in human pancreatic cancer cells |
| Q33997001 | Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients |
| Q34041533 | Solvent effects on structural and thermochemical properties of p53 tumor-suppressor gene: a molecular modeling approach in drug design |
| Q55060818 | TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer. |
| Q39052090 | The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer |
| Q34494019 | The molecular targets for the diagnosis and treatment of pancreatic cancer |
Search more.